Table 2.
Comparison of peptide repeat motifs (PRM) from seven countries to those of samples from Oman for csp, msp1, and msp3 alpha. Numbers highlighted in bold are samples with genotyping of three markers.
| Sample ID |
csp
|
msp1
|
msp3 alpha
|
||||||
|---|---|---|---|---|---|---|---|---|---|
| VK210 |
VK210 |
SSE | SSG | SSV | GSS | GTG | KKAE | KKAK | |
| A | B | ||||||||
| Brazil | 6 | 4 | 1 | 0 | 0 | 2 | 1 | 1 | 1 |
| El Salvador | 10 | 6 | 1 | 0 | 0 | 3 | 1 | 1 | 1 |
| Mauritania | 4 | 3 | 1 | 1 | 2 | 1 | 1 | 1 | 1 |
| Iran | 7 | 8 | – | – | – | – | – | – | – |
| India | 4 | 4 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Bangladesh | – | – | 1 | 0 | 0 | 1 | 1 | 1 | 1 |
| North Korea | 3 | 4 | 1 | 0 | 0 | 1 | 1 | 1 | 1 |
| 2 | 6 | 10 | 1 | 1 | 2 | 1 | 1 | 1 | 1 |
| 3 | 1 | 1 | |||||||
| 4 | 1 | 1 | 2 | 1 | 1 | ||||
| 6 | 1 | 1 | |||||||
| 7 | 1 | 1 | 2 | 1 | 1 | ||||
| 8 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | ||
| 9 | 1 | 1 | 2 | 1 | 1 | ||||
| 12 | 6 | 10 | 1 | 1 | |||||
| 13 | 1 | 1 | |||||||
| 17 | 1 | 1 | |||||||
| 19 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | ||
| 21 | 6 | 10 | 1 | 1 | |||||
| 22 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | ||
| 23 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | ||
| 24 | 6 | 10 | 1 | 1 | 2 | 1 | 1 | 1 | 1 |
| 25 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | ||
| 26 | 6 | 10 | 1 | 1 | 2 | 1 | 1 | 1 | 1 |
| 27 | 1 | 1 | 2 | 1 | 1 | ||||
| 28 | 1 | 1 | 2 | 1 | 1 | ||||
| 31 | 1 | 1 | 2 | 1 | 1 | ||||
| 32 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | ||
| 33 | 1 | 1 | 2 | 1 | 1 | ||||
| 34 | 1 | 1 | 2 | 1 | 1 | ||||
| 35 | 1 | 1 | |||||||
| 36 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | ||
| 37 | 6 | 10 | 1 | 1 | |||||
| 38 | 6 | 10 | |||||||
| 39 | 6 | 10 | 1 | 1 | 2 | 1 | 1 | ||
| 40 | 6 | 10 | |||||||
| 41 | 1 | 1 | |||||||
| 42 | 6 | 10 | 1 | 1 | 2 | 1 | 1 | 1 | 1 |
| 43 | 6 | 10 | 1 | 1 | |||||
| 45 | 6 | 10 | 1 | 1 | |||||
| 46 | 6 | 10 | 1 | 1 | |||||
| 47 | 6 | 10 | 1 | 1 | |||||
| 48 | 6 | 10 | 1 | 1 | 2 | 1 | 1 | ||
| 51 | 6 | 10 | |||||||
| 52 | 6 | 10 | 1 | 1 | |||||
| 53 | 6 | 10 | 1 | 1 | 2 | 1 | 1 | ||